Literature DB >> 25370039

Meconium ileus in a Lebanese family secondary to mutations in the GUCY2C gene.

Amanda Smith1, Dennis E Bulman1, Claire Goldsmith1, Eric Bareke2, Jacek Majewski2, Kym M Boycott1, Sarah M Nikkel1.   

Abstract

Meconium ileus is most often associated with mutations in the CFTR gene; however recently, mutations in GUCY2C in the Bedouin population have also been shown to result in this phenotype. This gene codes for an intestinal transmembrane receptor that generates cyclic GMP, which activates cystic fibrosis transmembrane receptor. We report a third family that supports the association of variants in the GUCY2C gene with meconium ileus (MI). A Lebanese kindred was studied and individuals affected with MI had either homozygous or compound heterozygous variants in GUCY2C. The earliest manifestation of the affected individuals was the presence of second trimester fetal echogenic bowel, thus resulting in the expansion of the differential diagnosis of this ultrasound finding.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25370039      PMCID: PMC4463511          DOI: 10.1038/ejhg.2014.236

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

Review 1.  Guanylyl cyclases and signaling by cyclic GMP.

Authors:  K A Lucas; G M Pitari; S Kazerounian; I Ruiz-Stewart; J Park; S Schulz; K P Chepenik; S A Waldman
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

2.  Meconium ileus in the absence of cystic fibrosis.

Authors:  K Fakhoury; P R Durie; H Levison; G J Canny
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

3.  Mutations in TMEM231 cause Joubert syndrome in French Canadians.

Authors:  Myriam Srour; Fadi F Hamdan; Jeremy A Schwartzentruber; Lysanne Patry; Luis H Ospina; Michael I Shevell; Valérie Désilets; Sylvia Dobrzeniecka; Géraldine Mathonnet; Emmanuelle Lemyre; Christine Massicotte; Damian Labuda; Dina Amrom; Eva Andermann; Guillaume Sébire; Bruno Maranda; Guy A Rouleau; Jacek Majewski; Jacques L Michaud
Journal:  J Med Genet       Date:  2012-09-25       Impact factor: 6.318

4.  Familial diarrhea syndrome caused by an activating GUCY2C mutation.

Authors:  Torunn Fiskerstrand; Najla Arshad; Bjørn Ivar Haukanes; Rune Rose Tronstad; Khanh Do-Cong Pham; Stefan Johansson; Bjarte Håvik; Siv L Tønder; Shawn E Levy; Damien Brackman; Helge Boman; Kabir Hassan Biswas; Jaran Apold; Nils Hovdenak; Sandhya S Visweswariah; Per M Knappskog
Journal:  N Engl J Med       Date:  2012-03-21       Impact factor: 91.245

Review 5.  Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C.

Authors:  Arie B Vaandrager
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

6.  Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C.

Authors:  Hila Romi; Idan Cohen; Daniella Landau; Suliman Alkrinawi; Baruch Yerushalmi; Reli Hershkovitz; Nitza Newman-Heiman; Garry R Cutting; Rivka Ofir; Sara Sivan; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2012-04-19       Impact factor: 11.025

7.  Distribution of heat-stable enterotoxin/guanylin receptors in the intestinal tract of man and other mammals.

Authors:  W J Krause; G L Cullingford; R H Freeman; S L Eber; K C Richardson; K F Fok; M G Currie; L R Forte
Journal:  J Anat       Date:  1994-04       Impact factor: 2.610

8.  Age-related differences in receptors for Escherichia coli heat-stable enterotoxin in the small and large intestine of children.

Authors:  M B Cohen; A Guarino; R Shukla; R A Giannella
Journal:  Gastroenterology       Date:  1988-02       Impact factor: 22.682

  8 in total
  12 in total

1.  Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.

Authors:  David S Weinberg; Jieru E Lin; Nathan R Foster; Gary Della'Zanna; Asad Umar; Drew Seisler; Walter K Kraft; David M Kastenberg; Leo C Katz; Paul J Limburg; Scott A Waldman
Journal:  Cancer Prev Res (Phila)       Date:  2017-04-10

Review 2.  Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain.

Authors:  Stuart M Brierley; Luke Grundy; Joel Castro; Andrea M Harrington; Gerhard Hannig; Michael Camilleri
Journal:  Trends Pharmacol Sci       Date:  2021-12-02       Impact factor: 14.819

Review 3.  Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.

Authors:  Hari Prasad; John Kandam Kulathu Mathew; Sandhya S Visweswariah
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

4.  Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers.

Authors:  David S Weinberg; Nathan R Foster; Gary Della'Zanna; Ryan P McMurray; Walter K Kraft; Angela Pallotto; David M Kastenberg; Leo C Katz; Christopher H Henry; Stephanie M Moleski; Paul J Limburg; Scott A Waldman
Journal:  Cancer Biol Ther       Date:  2021-10-10       Impact factor: 4.875

Review 5.  Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.

Authors:  Erik S Blomain; Dante J Merlino; Amanda M Pattison; Adam E Snook; Scott A Waldman
Journal:  Mol Pharmacol       Date:  2016-06-01       Impact factor: 4.436

6.  Novel GUCY2C variant causing familial diarrhea in a Mennonite kindred and a potential therapeutic approach.

Authors:  Rachel M Wolfe; Al-Walid Mohsen; Cate Walsh Vockley; Carol A Bertrand; Robert D Nicholls; Paige Heiman; Leah M Seibold; Jerry Vockley; Lina Ghaloul-Gonzalez
Journal:  Am J Med Genet A       Date:  2021-05-05       Impact factor: 2.802

7.  Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C.

Authors:  Thomas Müller; Insha Rasool; Peter Heinz-Erian; Eva Mildenberger; Christian Hülstrunk; Andreas Müller; Laurent Michaud; Bart G P Koot; Antje Ballauff; Julia Vodopiutz; Stefan Rosipal; Britt-Sabina Petersen; Andre Franke; Irene Fuchs; Heiko Witt; Heinz Zoller; Andreas R Janecke; Sandhya S Visweswariah
Journal:  Gut       Date:  2015-05-20       Impact factor: 23.059

Review 8.  The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia.

Authors:  Jeffrey A Rappaport; Scott A Waldman
Journal:  Front Oncol       Date:  2018-08-06       Impact factor: 6.244

Review 9.  Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders.

Authors:  Scott A Waldman; Michael Camilleri
Journal:  Gut       Date:  2018-03-21       Impact factor: 23.059

10.  Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.

Authors:  John C Flickinger; Jeffrey A Rappaport; Joshua R Barton; Trevor R Baybutt; Amanda M Pattison; Adam E Snook; Scott A Waldman
Journal:  Biomark Med       Date:  2021-01-20       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.